Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00302523
What this trial is testing

Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Nanjing University School of Medicine 16
Testing effectiveness (Phase 2)Study completedNCT05237388
What this trial is testing

Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Duke University 8
Testing effectiveness (Phase 2)Study completedNCT02141672
What this trial is testing

AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 265
Not applicableLooking for participantsNCT04924712
What this trial is testing

INS, B Cells and Microbiota

Who this might be right for
MicrobiotaB-lymphocytesGlomerulosclerosis+1 more
Nantes University Hospital 30
Large-scale testing (Phase 3)Study completedNCT01639339
What this trial is testing

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Human Genome Sciences Inc., a GSK Company 448
Early research (Phase 1)Looking for participantsNCT07491900
What this trial is testing

HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)
Hinge Bio 30
Post-approval studies (Phase 4)Study completedNCT01763580
What this trial is testing

Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

Who this might be right for
MCNSMinimal Change Nephrotic Syndrome (MCNS)
Astellas Pharma Korea, Inc. 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117
What this trial is testing

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT00935389
What this trial is testing

Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria

Who this might be right for
Lupus NephritisProteinuriaCTX
Nanjing University School of Medicine 44
Post-approval studies (Phase 4)UnknownNCT02231125
What this trial is testing

Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy

Who this might be right for
IgA Nephropathy
Chen Xiangmei 1,600
Testing effectiveness (Phase 2)Study completedNCT03649152
What this trial is testing

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Who this might be right for
Focal Segmental Glomerulosclerosis
Dimerix Bioscience Pty Ltd 8
Not applicableNot Yet RecruitingNCT07505576
What this trial is testing

Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

Who this might be right for
Lupus Nephritis
Assiut University 96
Large-scale testing (Phase 3)Study completedNCT03493685
What this trial is testing

Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Travere Therapeutics, Inc. 371
Not applicableStudy completedNCT03488368
What this trial is testing

Longterm Renal Oucomes of STOP-IgAN Trial Participants

Who this might be right for
IgA Nephropathy
RWTH Aachen University 148
Large-scale testing (Phase 3)Active Not RecruitingNCT05797610
What this trial is testing

Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Primary IgA Nephropathy
Hoffmann-La Roche 459
Testing effectiveness (Phase 2)Looking for participantsNCT05268289
What this trial is testing

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 240
Early research (Phase 1)Active Not RecruitingNCT06265220
What this trial is testing

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more
Artiva Biotherapeutics, Inc. 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT06580288
What this trial is testing

Effect of Finerenone in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Zhejiang University 120
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Testing effectiveness (Phase 2)Looking for participantsNCT05680480
What this trial is testing

Telitacicept in Lupus Nephritis

Who this might be right for
Lupus Nephritis
RemeGen Co., Ltd. 120
Next Page